Group One Trading, L.P. Corcept Therapeutics Inc Transaction History

Group One Trading, L.P.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	BUY	$19.95 - $29.96 $156,168 - $234,526	7,828 New	7,828 $158,000
Q3 2021 Nov 12, 2021	SELL	$19.68 - $22.53 $54,395 - $62,272	-2,764 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$19.97 - $24.43 $55,197 - $67,524	2,764 New	2,764 $61,000
Q2 2020 Aug 13, 2020	SELL	$11.0 - $18.26 $81,807 - $135,799	-7,437 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$10.11 - $14.04 $75,188 - $104,415	7,437 New	7,437 $88,000
Q4 2019 Feb 10, 2020	SELL	$12.06 - $16.96 $249,654 - $351,088	-20,701 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$10.41 - $14.66 $215,497 - $303,476	20,701 New	20,701 $293,000
Q2 2019 Aug 09, 2019	SELL	$9.78 - $12.76 $410,143 - $535,116	-41,937 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$10.03 - $15.71 $420,628 - $658,830	41,937 New	41,937 $492,000
Q2 2018 Aug 14, 2018	SELL	$15.3 - $19.69 $297,263 - $382,557	-19,429 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$14.59 - $25.5 $283,469 - $495,439	19,429 New	19,429 $320,000
Q3 2017 Nov 15, 2017	SELL	$12.3 - $19.3 $85,189 - $133,671	-6,926 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	6,926	6,926 $82,000

403

84.3M

1.04M

1.33M

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $5.87B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.